IMM 4.41% 35.5¢ immutep limited

share price - october

  1. 191 Posts.
    Hello all

    Sorry I have not been on here for a while so this may have already been discussed.
    PRR are releasing interim results from its CVac clinical trial CAN-003 in October 2012 and it appears some people are getting excited over this - Does the fact that they are planning to release this data at The International Gynecologic Cancer Society and are doing posters to do so tell us that the results are positive, I cant see them making a big thing out of it if they are not.

    This said would the market be thinking this way so is that news already being taken into consideration in the share price. If this is so we probably cant expect a spike in price in October.

    Also the fact Phase 3 trials are going ahead pretty much says phase 2 are looking good as well
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢
Change
0.015(4.41%)
Mkt cap ! $515.6M
Open High Low Value Volume
34.0¢ 36.0¢ 34.0¢ $1.270M 3.611M

Buyers (Bids)

No. Vol. Price($)
7 286261 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 253490 7
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.